4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001193125-26-410001
Chief Financial Officer bought 15,000 shares at $37.32 ($559,740)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kelly Thomas Patrick Chief Financial Officer | 2026-09-30 | Purchase | +15,000 | $37.32 | $559,740 | 15,000 | D |
| Open-market purchases · 15,000 sh · avg $37.32 · $559,740 | |||||||
Loading xslF345X06/ownership.xml…